Here's Why You Should Invest in BioMarin Pharmaceutical (BMRN)

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” first quarter 2023 investor letter. A copy of the same can be downloaded here.

Related Keywords

California ,United States , ,Biomarin Pharmaceutical Inc ,Nasdaq ,Health Care ,Holdings In Information Technology ,Aristotle Atlantic Partners ,Cap Growth ,Aristotle Atlantic ,Large Cap Growth Strategy ,Information Technology ,Consumer Discretionary ,Atlantic Large Cap Growth Strategy ,Biomarin Pharmaceutical ,San Rafael ,Marin Pharmaceutical ,Severe Hemophilia ,Popular Stocks Among Hedge ,Clearbridge Sustainability Leaders Strategy ,